🇺🇸 FDA

Drug profile · INN

sodium polystyrene sulfonate

RESONIUM-A

FDA: approved TGA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

sodium polystyrene sulfonate (RESONIUM-A) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: oral, rectal. Current US regulatory status: approved.

Key facts

INN sodium polystyrene sulfonate
Brand RESONIUM-A
Route ORAL, RECTAL
Formulation POWDER
Originator Sanofi-aventis Healthcare Pty Ltd

Frequently asked questions

What is sodium polystyrene sulfonate?

sodium polystyrene sulfonate (RESONIUM-A) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: oral, rectal. Current US regulatory status: approved.

What is the brand name for sodium polystyrene sulfonate?

RESONIUM-A is a marketed brand name for sodium polystyrene sulfonate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium polystyrene sulfonate?

sodium polystyrene sulfonate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.